Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A collaboration with Prof Johann DeBono (ICR)

Clare Verrill, Johann DeBono, Jens Rittscher and others

This builds on collaboration within the 100,000 Genomes Project Prostate Genomic Clinical Interpretation Partnership (GeCIP) (DeBono – lead, Verrill – member)

Utilising a unique cohort of castrate resistant (hormone resistant) prostate cancers based at ICR, which have undergone extensive molecular testing, we will seek to develop a urological pathologist expert panel based grading system which will seek to predict time to adverse outcome (progression, death).  This exercise will then be undertaken by machine based learning methods, in order to either augment or improve upon the expert based grading system.